Rais Laboratoires: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Rais Laboratoires
Largest movements
- Receivables within one year -€2,979
down €2,979 (-11.5%), from €25,901 to €22,923
of which Trade receivables: -€1,525
- Deferred charges and accrued income -€1,408
no longer reported in 2025 (was €1,408)
- Trade debts -€4,909
no longer reported in 2025 (was €4,909)
- Profit (loss) carried forward +€940
up €940 (+32.5%), from -€2,892 to -€1,952
- Other debts -€411
no longer reported in 2025 (was €411)
- Gross operating margin +€4,984
up €4,984, from -€3,858 to €1,126
- Financial income -€1,288
no longer reported in 2025 (was €1,288)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €27,611 | €23,048 | -€4,563 | -16.5% |
| Current assets | 29/58 | €27,611 | €23,048 | -€4,563 | -16.5% |
| Amounts receivable within one year | 40/41 | €25,901 | €22,923 | -€2,979 | -11.5% |
| Trade receivables | 40 | €1,525 | - | -€1,525 | |
| Other amounts receivable | 41 | €24,377 | €22,923 | -€1,454 | -6.0% |
| Cash at bank and in hand | 54/58 | €302 | €125 | -€177 | -58.5% |
| Deferred charges and accrued income | 490/1 | €1,408 | - | -€1,408 | |
| Total equity and liabilities | 10/49 | €27,611 | €23,048 | -€4,563 | -16.5% |
| Equity | 10/15 | €22,108 | €23,048 | +€940 | +4.3% |
| Contributions | 10/11 | €25,000 | €25,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€2,892 | -€1,952 | +€940 | +32.5% |
| Amounts payable | 17/49 | €5,503 | - | -€5,503 | |
| Amounts payable within one year | 42/48 | €5,491 | - | -€5,491 | |
| Trade debts | 44 | €4,909 | - | -€4,909 | |
| Suppliers | 440/4 | €4,909 | - | -€4,909 | |
| Taxes, remuneration and social security | 45 | €171 | - | -€171 | |
| Taxes | 450/3 | €171 | - | -€171 | |
| Other amounts payable | 47/48 | €411 | - | -€411 | |
| Accrued charges and deferred income | 492/3 | €12 | - | -€12 | |
| Other operating charges | 640/8 | €141 | €144 | +€4 | +2.6% |
| Gross operating margin | 9900 | -€3,858 | €1,126 | +€4,984 | |
| Operating profit (loss) | 9901 | -€3,998 | €982 | +€4,981 | |
| Financial income | 75/76B | €1,288 | - | -€1,288 | |
| Recurring financial income | 75 | €1,288 | - | -€1,288 | |
| Financial charges | 65/66B | €59 | €42 | -€16 | -28.0% |
| Recurring financial charges | 65 | €59 | €42 | -€16 | -28.0% |
| Profit (loss) for the period before taxes | 9903 | -€2,769 | €940 | +€3,709 | |
| Profit (loss) for the period | 9904 | -€2,769 | €940 | +€3,709 | |
| Profit (loss) for the period to be appropriated | 9905 | -€2,769 | €940 | +€3,709 |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.